CA2551133A1 - Reparation de defauts de l'anneau fibreux vertebral et regeneration par annuloplastie / nucleoplastie - Google Patents
Reparation de defauts de l'anneau fibreux vertebral et regeneration par annuloplastie / nucleoplastie Download PDFInfo
- Publication number
- CA2551133A1 CA2551133A1 CA002551133A CA2551133A CA2551133A1 CA 2551133 A1 CA2551133 A1 CA 2551133A1 CA 002551133 A CA002551133 A CA 002551133A CA 2551133 A CA2551133 A CA 2551133A CA 2551133 A1 CA2551133 A1 CA 2551133A1
- Authority
- CA
- Canada
- Prior art keywords
- reticulated
- elastomeric
- another embodiment
- foam
- elastomeric matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000007547 defect Effects 0.000 title claims abstract description 20
- 230000008439 repair process Effects 0.000 title claims abstract description 18
- 230000008929 regeneration Effects 0.000 title claims abstract description 13
- 238000011069 regeneration method Methods 0.000 title claims abstract description 13
- 210000001519 tissue Anatomy 0.000 claims abstract description 49
- 239000000203 mixture Substances 0.000 claims abstract description 45
- 210000002808 connective tissue Anatomy 0.000 claims abstract 2
- 239000011159 matrix material Substances 0.000 claims description 150
- 239000011148 porous material Substances 0.000 claims description 88
- 239000000463 material Substances 0.000 claims description 67
- 238000000034 method Methods 0.000 claims description 49
- 229920005862 polyol Polymers 0.000 claims description 47
- 150000003077 polyols Chemical class 0.000 claims description 45
- 239000012948 isocyanate Substances 0.000 claims description 41
- 150000002513 isocyanates Chemical class 0.000 claims description 38
- 238000000576 coating method Methods 0.000 claims description 35
- -1 polysiloxane Polymers 0.000 claims description 35
- 239000011248 coating agent Substances 0.000 claims description 33
- 238000007906 compression Methods 0.000 claims description 33
- 230000006835 compression Effects 0.000 claims description 33
- 229920002635 polyurethane Polymers 0.000 claims description 33
- 239000004814 polyurethane Substances 0.000 claims description 33
- 102000008186 Collagen Human genes 0.000 claims description 29
- 108010035532 Collagen Proteins 0.000 claims description 29
- 229920001436 collagen Polymers 0.000 claims description 29
- 239000004417 polycarbonate Substances 0.000 claims description 25
- 229920000515 polycarbonate Polymers 0.000 claims description 23
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 21
- 230000002209 hydrophobic effect Effects 0.000 claims description 19
- 230000001413 cellular effect Effects 0.000 claims description 18
- 229920001296 polysiloxane Polymers 0.000 claims description 13
- 230000035755 proliferation Effects 0.000 claims description 12
- 150000002009 diols Chemical class 0.000 claims description 11
- 238000011084 recovery Methods 0.000 claims description 10
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 238000000338 in vitro Methods 0.000 claims description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 7
- 102000016942 Elastin Human genes 0.000 claims description 7
- 108010014258 Elastin Proteins 0.000 claims description 7
- 229920002549 elastin Polymers 0.000 claims description 7
- 229960003160 hyaluronic acid Drugs 0.000 claims description 7
- 229920002725 thermoplastic elastomer Polymers 0.000 claims description 7
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- LFSYUSUFCBOHGU-UHFFFAOYSA-N 1-isocyanato-2-[(4-isocyanatophenyl)methyl]benzene Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=CC=C1N=C=O LFSYUSUFCBOHGU-UHFFFAOYSA-N 0.000 claims description 3
- 108010067306 Fibronectins Proteins 0.000 claims description 3
- 102000016359 Fibronectins Human genes 0.000 claims description 3
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 claims description 2
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 claims description 2
- CDMDQYCEEKCBGR-UHFFFAOYSA-N 1,4-diisocyanatocyclohexane Chemical compound O=C=NC1CCC(N=C=O)CC1 CDMDQYCEEKCBGR-UHFFFAOYSA-N 0.000 claims description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 2
- 239000005058 Isophorone diisocyanate Substances 0.000 claims description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 2
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims 2
- 229920000570 polyether Polymers 0.000 claims 2
- AZYRZNIYJDKRHO-UHFFFAOYSA-N 1,3-bis(2-isocyanatopropan-2-yl)benzene Chemical compound O=C=NC(C)(C)C1=CC=CC(C(C)(C)N=C=O)=C1 AZYRZNIYJDKRHO-UHFFFAOYSA-N 0.000 claims 1
- 239000004721 Polyphenylene oxide Substances 0.000 claims 1
- 239000002407 tissue scaffold Substances 0.000 claims 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 claims 1
- RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
- 239000006260 foam Substances 0.000 description 95
- 239000007943 implant Substances 0.000 description 77
- 210000004027 cell Anatomy 0.000 description 40
- 239000013543 active substance Substances 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 239000007788 liquid Substances 0.000 description 28
- 229920000642 polymer Polymers 0.000 description 27
- 238000012360 testing method Methods 0.000 description 27
- 210000005036 nerve Anatomy 0.000 description 21
- 208000002193 Pain Diseases 0.000 description 19
- 208000008035 Back Pain Diseases 0.000 description 18
- 238000002513 implantation Methods 0.000 description 18
- 230000035699 permeability Effects 0.000 description 17
- 239000002904 solvent Substances 0.000 description 17
- 238000004132 cross linking Methods 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 238000001727 in vivo Methods 0.000 description 15
- 239000004604 Blowing Agent Substances 0.000 description 14
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 13
- 238000002156 mixing Methods 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 239000011800 void material Substances 0.000 description 12
- 229920001971 elastomer Polymers 0.000 description 11
- 239000000806 elastomer Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 11
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 10
- 229920000954 Polyglycolide Polymers 0.000 description 10
- 229920001247 Reticulated foam Polymers 0.000 description 10
- 238000007664 blowing Methods 0.000 description 10
- 239000003054 catalyst Substances 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 230000000399 orthopedic effect Effects 0.000 description 10
- 229920000117 poly(dioxanone) Polymers 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 238000013459 approach Methods 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000002131 composite material Substances 0.000 description 9
- 230000007794 irritation Effects 0.000 description 9
- 230000033001 locomotion Effects 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 239000007858 starting material Substances 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 239000004970 Chain extender Substances 0.000 description 8
- 230000007850 degeneration Effects 0.000 description 8
- 238000005187 foaming Methods 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
- 229920000747 poly(lactic acid) Polymers 0.000 description 8
- 239000004626 polylactic acid Substances 0.000 description 8
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 7
- 229920001688 coating polymer Polymers 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 230000004927 fusion Effects 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 238000009864 tensile test Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 101100184147 Caenorhabditis elegans mix-1 gene Proteins 0.000 description 6
- 108091006146 Channels Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 208000018180 degenerative disc disease Diseases 0.000 description 6
- 230000000994 depressogenic effect Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000011065 in-situ storage Methods 0.000 description 6
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 6
- 210000004705 lumbosacral region Anatomy 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 238000001000 micrograph Methods 0.000 description 6
- 210000001640 nerve ending Anatomy 0.000 description 6
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 230000002194 synthesizing effect Effects 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 239000003102 growth factor Substances 0.000 description 5
- 238000000399 optical microscopy Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 210000002517 zygapophyseal joint Anatomy 0.000 description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 229920000249 biocompatible polymer Polymers 0.000 description 4
- 239000013060 biological fluid Substances 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 229910001882 dioxygen Inorganic materials 0.000 description 4
- 238000004880 explosion Methods 0.000 description 4
- 210000000968 fibrocartilage Anatomy 0.000 description 4
- 210000000497 foam cell Anatomy 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229910001000 nickel titanium Inorganic materials 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000002787 reinforcement Effects 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 229920001169 thermoplastic Polymers 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 102100031168 CCN family member 2 Human genes 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 239000004971 Cross linker Substances 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 3
- 208000020307 Spinal disease Diseases 0.000 description 3
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000012973 diazabicyclooctane Substances 0.000 description 3
- 125000005442 diisocyanate group Chemical group 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 239000003527 fibrinolytic agent Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 239000011824 nuclear material Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000011555 rabbit model Methods 0.000 description 3
- 238000004513 sizing Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 229910052715 tantalum Inorganic materials 0.000 description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 3
- 239000004416 thermosoftening plastic Substances 0.000 description 3
- 230000008467 tissue growth Effects 0.000 description 3
- 239000004034 viscosity adjusting agent Substances 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- UBOXGVDOUJQMTN-UHFFFAOYSA-N 1,1,2-trichloroethane Chemical compound ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 102100031171 CCN family member 1 Human genes 0.000 description 2
- 102100031170 CCN family member 3 Human genes 0.000 description 2
- 102100031173 CCN family member 4 Human genes 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
- 102100025175 Cellular communication network factor 6 Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010039419 Connective Tissue Growth Factor Proteins 0.000 description 2
- 108010019961 Cysteine-Rich Protein 61 Proteins 0.000 description 2
- 102000003951 Erythropoietin Human genes 0.000 description 2
- 108090000394 Erythropoietin Proteins 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- 102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 description 2
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 2
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010013731 Myelin-Associated Glycoprotein Proteins 0.000 description 2
- 102100021831 Myelin-associated glycoprotein Human genes 0.000 description 2
- 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 2
- 102100023616 Neural cell adhesion molecule L1-like protein Human genes 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 102100035194 Placenta growth factor Human genes 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 101710142969 Somatoliberin Proteins 0.000 description 2
- 102100038803 Somatotropin Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 108090000054 Syndecan-2 Proteins 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000003399 chemotactic effect Effects 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 229960005188 collagen Drugs 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 229940105423 erythropoietin Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 102000028416 insulin-like growth factor binding Human genes 0.000 description 2
- 108091022911 insulin-like growth factor binding Proteins 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 229940047122 interleukins Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 102000036209 mannose binding proteins Human genes 0.000 description 2
- 108020003928 mannose binding proteins Proteins 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000002997 osteoclast Anatomy 0.000 description 2
- 210000004409 osteocyte Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920001245 poly(D,L-lactide-co-caprolactone) Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920003226 polyurethane urea Polymers 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 238000011417 postcuring Methods 0.000 description 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000002437 synoviocyte Anatomy 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- NNRFRJQMBSBXGO-CIUDSAMLSA-N (3s)-3-[[2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NNRFRJQMBSBXGO-CIUDSAMLSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- UMZVBZDHGKJFGQ-UHFFFAOYSA-N 1-[2-[[2-[[2-[[2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid Chemical compound NC(N)=NCCCC(NC(=O)CN)C(=O)NCC(=O)NC(CC(O)=O)C(=O)NC(C(O)C)C(=O)N1CCCC1C(O)=O UMZVBZDHGKJFGQ-UHFFFAOYSA-N 0.000 description 1
- JVJUWEFOGFCHKR-UHFFFAOYSA-N 2-(diethylamino)ethyl 1-(3,4-dimethylphenyl)cyclopentane-1-carboxylate;hydrochloride Chemical compound Cl.C=1C=C(C)C(C)=CC=1C1(C(=O)OCCN(CC)CC)CCCC1 JVJUWEFOGFCHKR-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- 101150079978 AGRN gene Proteins 0.000 description 1
- 102100036601 Aggrecan core protein Human genes 0.000 description 1
- 108010067219 Aggrecans Proteins 0.000 description 1
- 102100040026 Agrin Human genes 0.000 description 1
- 108700019743 Agrin Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009840 Angiopoietins Human genes 0.000 description 1
- 108010009906 Angiopoietins Proteins 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 102100036597 Basement membrane-specific heparan sulfate proteoglycan core protein Human genes 0.000 description 1
- 102000004954 Biglycan Human genes 0.000 description 1
- 108090001138 Biglycan Proteins 0.000 description 1
- 101710137353 CCN family member 4 Proteins 0.000 description 1
- 102100025215 CCN family member 5 Human genes 0.000 description 1
- 101710137354 CCN family member 5 Proteins 0.000 description 1
- 101150036984 CCN3 gene Proteins 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 108010084313 CD58 Antigens Proteins 0.000 description 1
- 108010062802 CD66 antigens Proteins 0.000 description 1
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 101710118748 Cellular communication network factor 6 Proteins 0.000 description 1
- 108010078239 Chemokine CX3CL1 Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 102000002029 Claudin Human genes 0.000 description 1
- 108050009302 Claudin Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000010970 Connexin Human genes 0.000 description 1
- 108050001175 Connexin Proteins 0.000 description 1
- 102100024342 Contactin-2 Human genes 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102100021899 Cyclin-L2 Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004237 Decorin Human genes 0.000 description 1
- 108090000738 Decorin Proteins 0.000 description 1
- 102000006375 Desmocollins Human genes 0.000 description 1
- 108010019063 Desmocollins Proteins 0.000 description 1
- 102000011799 Desmoglein Human genes 0.000 description 1
- 108050002238 Desmoglein Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000012276 Endovascular treatment Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000009842 Fibril-Associated Collagens Human genes 0.000 description 1
- 108010020305 Fibril-Associated Collagens Proteins 0.000 description 1
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 1
- 102000017177 Fibromodulin Human genes 0.000 description 1
- 108010013996 Fibromodulin Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102100028314 Filaggrin Human genes 0.000 description 1
- 101710088660 Filaggrin Proteins 0.000 description 1
- 102100020997 Fractalkine Human genes 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 102000030902 Galactosyltransferase Human genes 0.000 description 1
- 108060003306 Galactosyltransferase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000010956 Glypican Human genes 0.000 description 1
- 108050001154 Glypican Proteins 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 229940122853 Growth hormone antagonist Drugs 0.000 description 1
- 102000008055 Heparan Sulfate Proteoglycans Human genes 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 1
- 101000777560 Homo sapiens CCN family member 4 Proteins 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000934310 Homo sapiens Cellular communication network factor 6 Proteins 0.000 description 1
- 101000909516 Homo sapiens Contactin-2 Proteins 0.000 description 1
- 101000897452 Homo sapiens Cyclin-L2 Proteins 0.000 description 1
- 101001041117 Homo sapiens Hyaluronidase PH-20 Proteins 0.000 description 1
- 101001001487 Homo sapiens Phosphatidylinositol-glycan biosynthesis class F protein Proteins 0.000 description 1
- 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 description 1
- 101000829980 Homo sapiens Ral guanine nucleotide dissociation stimulator Proteins 0.000 description 1
- 101000899806 Homo sapiens Retinal guanylyl cyclase 1 Proteins 0.000 description 1
- 108010013214 Hyaluronan Receptors Proteins 0.000 description 1
- 102000018866 Hyaluronan Receptors Human genes 0.000 description 1
- 102100021102 Hyaluronidase PH-20 Human genes 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
- 108010028750 Integrin-Binding Sialoprotein Proteins 0.000 description 1
- 102000016921 Integrin-Binding Sialoprotein Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010013709 Leukocyte Common Antigens Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 108010072582 Matrilin Proteins Proteins 0.000 description 1
- 102000055008 Matrilin Proteins Human genes 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 102000015728 Mucins Human genes 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 108700024729 Nephroblastoma Overexpressed Proteins 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 108010063605 Netrins Proteins 0.000 description 1
- 102000010803 Netrins Human genes 0.000 description 1
- 102100035414 Neurofascin Human genes 0.000 description 1
- 101710189786 Neurofascin Proteins 0.000 description 1
- 102000000641 Non-Fibrillar Collagens Human genes 0.000 description 1
- 108010002466 Non-Fibrillar Collagens Proteins 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 1
- 102000003940 Occludin Human genes 0.000 description 1
- 108090000304 Occludin Proteins 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000009890 Osteonectin Human genes 0.000 description 1
- 108010077077 Osteonectin Proteins 0.000 description 1
- 102000004264 Osteopontin Human genes 0.000 description 1
- 108010081689 Osteopontin Proteins 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 108010082093 Placenta Growth Factor Proteins 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 108010077971 Plasminogen Inactivators Proteins 0.000 description 1
- 102000010752 Plasminogen Inactivators Human genes 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 102100023320 Ral guanine nucleotide dissociation stimulator Human genes 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 102000014105 Semaphorin Human genes 0.000 description 1
- 108050003978 Semaphorin Proteins 0.000 description 1
- 102100022791 Sodium/potassium-transporting ATPase subunit beta-2 Human genes 0.000 description 1
- 101710193880 Sodium/potassium-transporting ATPase subunit beta-2 Proteins 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 102000019361 Syndecan Human genes 0.000 description 1
- 108050006774 Syndecan Proteins 0.000 description 1
- 102000003711 Syndecan-2 Human genes 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 102000007000 Tenascin Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 102100028644 Tenascin-R Human genes 0.000 description 1
- 229940122388 Thrombin inhibitor Drugs 0.000 description 1
- 108060008245 Thrombospondin Proteins 0.000 description 1
- 102000002938 Thrombospondin Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 description 1
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 231100000764 actin inhibitor Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000003409 anti-rejection Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- RAURUSFBVQLAPW-DNIKMYEQSA-N clocinnamox Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)NC(=O)\C=C\C=2C=CC(Cl)=CC=2)CC1)O)CC1CC1 RAURUSFBVQLAPW-DNIKMYEQSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- SLPJGDQJLTYWCI-UHFFFAOYSA-N dimethyl-(4,5,6,7-tetrabromo-1h-benzoimidazol-2-yl)-amine Chemical compound BrC1=C(Br)C(Br)=C2NC(N(C)C)=NC2=C1Br SLPJGDQJLTYWCI-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940052760 dopamine agonists Drugs 0.000 description 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 210000003890 endocrine cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003733 fiber-reinforced composite Substances 0.000 description 1
- 108060002894 fibrillar collagen Proteins 0.000 description 1
- 102000013373 fibrillar collagen Human genes 0.000 description 1
- 102000013370 fibrillin Human genes 0.000 description 1
- 108060002895 fibrillin Proteins 0.000 description 1
- 108010000421 fibronectin attachment peptide Proteins 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000001497 fibrovascular Effects 0.000 description 1
- 102000006482 fibulin Human genes 0.000 description 1
- 108010044392 fibulin Proteins 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000010128 melt processing Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 231100000782 microtubule inhibitor Toxicity 0.000 description 1
- 238000012978 minimally invasive surgical procedure Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 229940051875 mucins Drugs 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 210000003098 myoblast Anatomy 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 108010008217 nidogen Proteins 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100001223 noncarcinogenic Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000000849 parathyroid Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 108010049224 perlecan Proteins 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 102000005162 pleiotrophin Human genes 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 1
- 210000002908 protein secreting cell Anatomy 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000003439 radiotherapeutic effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 108010050065 serglycin Proteins 0.000 description 1
- 102000015340 serglycin Human genes 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000005477 standard model Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000002731 stomach secretion inhibitor Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 108010020387 tenascin R Proteins 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003868 thrombin inhibitor Substances 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229910000348 titanium sulfate Inorganic materials 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 108010047303 von Willebrand Factor Proteins 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
- 229960001134 von willebrand factor Drugs 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws or setting implements
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/70—Spinal positioners or stabilisers, e.g. stabilisers comprising fluid filler in an implant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0095—Packages or dispensers for prostheses or other implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
- A61F2002/30064—Coating or prosthesis-covering structure made of biodegradable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30072—Coating made of plastically deformable or self-moulding material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/3008—Properties of materials and coating materials radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30579—Special structural features of bone or joint prostheses not otherwise provided for with mechanically expandable devices, e.g. fixation devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3092—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/4435—Support means or repair of the natural disc wall, i.e. annulus, e.g. using plates, membranes or meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/4445—Means for culturing intervertebral disc tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools for implanting artificial joints
- A61F2002/4677—Special tools for implanting artificial joints using a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/0097—Coating or prosthesis-covering structure made of pharmaceutical products, e.g. antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00976—Coating or prosthesis-covering structure made of proteins or of polypeptides, e.g. of bone morphogenic proteins BMP or of transforming growth factors TGF
Landscapes
- Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
La présente invention concerne la réparation de défauts de l'anneau fibreux vertébral. A cet effet, un appareil comporte une structure constituée d'une composition élastomère réticulée biodurable et pouvant être comprimée de manière élastique pour éliminer les défauts des tissus conjonctifs vertébraux, pour éliminer les défauts des tissus annulaires et nucléaires vertébraux et pour la régénération par annuloplastie / nucléoplastie vertébrale. Ledit appareil comporte un élément au moins partiellement cylindrique.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/746,563 US7763077B2 (en) | 2003-12-24 | 2003-12-24 | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
| US10/746,563 | 2003-12-24 | ||
| PCT/US2004/043455 WO2005065280A2 (fr) | 2003-12-24 | 2004-12-23 | Reparation de defauts de l'anneau fibreux vertebral et regeneration par annuloplastie / nucleoplastie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2551133A1 true CA2551133A1 (fr) | 2005-07-21 |
Family
ID=34710707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002551133A Abandoned CA2551133A1 (fr) | 2003-12-24 | 2004-12-23 | Reparation de defauts de l'anneau fibreux vertebral et regeneration par annuloplastie / nucleoplastie |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7763077B2 (fr) |
| EP (1) | EP1697082A2 (fr) |
| JP (1) | JP2007531557A (fr) |
| AU (1) | AU2004311838A1 (fr) |
| CA (1) | CA2551133A1 (fr) |
| WO (1) | WO2005065280A2 (fr) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7094258B2 (en) | 1999-08-18 | 2006-08-22 | Intrinsic Therapeutics, Inc. | Methods of reinforcing an annulus fibrosis |
| WO2004100841A1 (fr) | 1999-08-18 | 2004-11-25 | Intrinsic Therapeutics, Inc. | Dispositifs et procedes de densification du noyau du disque vertebral |
| US7972337B2 (en) | 2005-12-28 | 2011-07-05 | Intrinsic Therapeutics, Inc. | Devices and methods for bone anchoring |
| US7998213B2 (en) | 1999-08-18 | 2011-08-16 | Intrinsic Therapeutics, Inc. | Intervertebral disc herniation repair |
| JP4247519B2 (ja) | 1999-08-18 | 2009-04-02 | イントリンジック セラピューティックス インコーポレイテッド | 髄核オーグメンテーションおよび保定のための装置および方法 |
| US8323341B2 (en) | 2007-09-07 | 2012-12-04 | Intrinsic Therapeutics, Inc. | Impaction grafting for vertebral fusion |
| US7717961B2 (en) | 1999-08-18 | 2010-05-18 | Intrinsic Therapeutics, Inc. | Apparatus delivery in an intervertebral disc |
| US7744651B2 (en) | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
| US20040054414A1 (en) | 2002-09-18 | 2004-03-18 | Trieu Hai H. | Collagen-based materials and methods for augmenting intervertebral discs |
| CN100394989C (zh) | 2002-11-15 | 2008-06-18 | 华沙整形外科股份有限公司 | 包含微粒状基于胶原材料的组合物的制药应用和包含所述组合物的滑膜关节 |
| AU2004241111B2 (en) | 2003-05-15 | 2010-05-27 | Dsm Ip Assets B.V | Manufacture and use of implantable reticulated elastomeric matrices |
| US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
| US8771294B2 (en) | 2004-11-26 | 2014-07-08 | Biomerix Corporation | Aneurysm treatment devices and methods |
| CN101541266A (zh) * | 2005-11-21 | 2009-09-23 | 尼卡斯特有限公司 | 脊束核假体装置 |
| US7723422B2 (en) * | 2005-12-23 | 2010-05-25 | Boston Scientific Scimed, Inc. | Functionalized block copolymers |
| US20070208426A1 (en) * | 2006-03-03 | 2007-09-06 | Sdgi Holdings, Inc. | Spinal implant with improved surface properties for delivery |
| GB0605960D0 (en) * | 2006-03-24 | 2006-05-03 | Galley Geoffrey H | Expandable spinal prosthesis |
| US8399619B2 (en) | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
| US20080004431A1 (en) * | 2006-06-30 | 2008-01-03 | Warsaw Orthopedic Inc | Method of manufacturing an injectable collagen material |
| US20080004703A1 (en) * | 2006-06-30 | 2008-01-03 | Warsaw Orthopedic, Inc. | Method of treating a patient using a collagen material |
| US8118779B2 (en) | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
| US20080082170A1 (en) * | 2006-09-29 | 2008-04-03 | Peterman Marc M | Apparatus and methods for surgical repair |
| US20080107711A1 (en) * | 2006-11-08 | 2008-05-08 | Alexis Paul Shelokov | Bioabsorbable Implantable Material Fortified with Antibiotics for Localized Delivery of Drugs |
| US8377016B2 (en) * | 2007-01-10 | 2013-02-19 | Wake Forest University Health Sciences | Apparatus and method for wound treatment employing periodic sub-atmospheric pressure |
| US20080300684A1 (en) * | 2007-05-31 | 2008-12-04 | Shelokov Alexis P | System and method for controlled delivery of bone morphogenic protein and other bone graft substitutes for bone formation, repair and healing |
| US7867263B2 (en) * | 2007-08-07 | 2011-01-11 | Transcorp, Inc. | Implantable bone plate system and related method for spinal repair |
| US8709054B2 (en) * | 2007-08-07 | 2014-04-29 | Transcorp, Inc. | Implantable vertebral frame systems and related methods for spinal repair |
| US20090099568A1 (en) * | 2007-08-07 | 2009-04-16 | David Lowry | Device and method for variably adjusting intervertebral distraction and lordosis |
| US20110196492A1 (en) | 2007-09-07 | 2011-08-11 | Intrinsic Therapeutics, Inc. | Bone anchoring systems |
| EP2564793B1 (fr) * | 2007-09-13 | 2014-08-20 | Transcorp, Inc. | Décompression de colonne vertébrale transcorporéale et système de réparation |
| US20090076516A1 (en) * | 2007-09-13 | 2009-03-19 | David Lowry | Device and method for tissue retraction in spinal surgery |
| US8430882B2 (en) | 2007-09-13 | 2013-04-30 | Transcorp, Inc. | Transcorporeal spinal decompression and repair systems and related methods |
| WO2009045912A2 (fr) * | 2007-09-28 | 2009-04-09 | Transcorp, Inc. | Rétracteur de tissu monté sur vertèbre et procédé d'utilisation en chirurgie spinale |
| US20090112332A1 (en) * | 2007-10-31 | 2009-04-30 | Alexis Paul Shelokov | Bone graft and bone graft substitutes with antibiotics for sustained, localized release of antibiotics for reducing postoperative surgical wound infection in spinal and other bone surgery |
| WO2009070607A1 (fr) | 2007-11-27 | 2009-06-04 | Transcorp, Inc. | Procédés et systèmes pour réparer un disque intervertébral à l'aide d'une approche transcorporelle |
| US20110153022A1 (en) * | 2008-05-30 | 2011-06-23 | Synthes Usa, Llc | Balloon-assisted annulus repair |
| WO2010009294A1 (fr) | 2008-07-18 | 2010-01-21 | Wake Forest University Heath Sciences | Appareil et procédé pour la modulation du tissu cardiaque par application topique de vide afin de réduire au minimum la mort et les dommages cellulaires |
| US8801801B2 (en) * | 2009-04-03 | 2014-08-12 | Biomerix Corporation | At least partially resorbable reticulated elastomeric matrix elements and methods of making same |
| WO2011003133A1 (fr) * | 2009-07-06 | 2011-01-13 | Tony Goldschlager | Procédé et outil chirurgicaux |
| US8273110B2 (en) * | 2009-09-22 | 2012-09-25 | Globus Medical, Inc. | System and method for installing an annular repair rivet through a vertebral body port |
| US8425569B2 (en) | 2010-05-19 | 2013-04-23 | Transcorp, Inc. | Implantable vertebral frame systems and related methods for spinal repair |
| WO2012097381A1 (fr) * | 2011-01-14 | 2012-07-19 | Biomerix Corporation | Éléments matriciels élastomères réticulés au moins partiellement résorbables et leurs procédés de fabrication |
| US9114190B2 (en) | 2013-02-08 | 2015-08-25 | Laser Spine Institute, Llc | Regeneration of spinal discs |
| US10561503B2 (en) * | 2015-07-21 | 2020-02-18 | Aleeva Medical Inc. | Method for relieving pain and regenerating intervertebral disc |
| CA3000757A1 (fr) * | 2015-11-06 | 2017-05-11 | University Health Network | Compositions et methodes destinees a la regeneration de degenerescence discale |
| DE102016124049B4 (de) * | 2016-12-12 | 2018-09-27 | Christoph Karl | Gelenkimplantat zur Gewebeneubildung am Gelenk |
Family Cites Families (451)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US14118A (en) * | 1856-01-15 | stare | ||
| US198599A (en) * | 1877-12-25 | Improvement in tents | ||
| US1896071A (en) | 1931-04-24 | 1933-02-07 | George A Clark | Pessary |
| US2546754A (en) | 1947-11-19 | 1951-03-27 | Jones John Leslie | Vaginal applicator |
| US2616422A (en) | 1948-10-18 | 1952-11-04 | Jones John Leslie | Vaginal applicator |
| US3279996A (en) | 1962-08-28 | 1966-10-18 | Jr David M Long | Polysiloxane carrier for controlled release of drugs and other agents |
| US3175025A (en) | 1963-04-05 | 1965-03-23 | Chemotronics International Inc | Process for bonding and/or reticulation |
| US3334629A (en) | 1964-11-09 | 1967-08-08 | Bertram D Cohn | Occlusive device for inferior vena cava |
| US3896819A (en) | 1969-04-01 | 1975-07-29 | Alejandro Zaffaroni | IUD having a replenishing drug reservoir |
| US3789841A (en) | 1971-09-15 | 1974-02-05 | Becton Dickinson Co | Disposable guide wire |
| US6436135B1 (en) | 1974-10-24 | 2002-08-20 | David Goldfarb | Prosthetic vascular graft |
| US3946106A (en) | 1974-10-24 | 1976-03-23 | G. D. Searle & Co. | Microsealed pharmaceutical delivery device |
| US4374669A (en) | 1975-05-09 | 1983-02-22 | Mac Gregor David C | Cardiovascular prosthetic devices and implants with porous systems |
| US4282199A (en) | 1980-02-25 | 1981-08-04 | J. M. Huber Corporation | Carbon black process |
| US4315844A (en) | 1980-07-08 | 1982-02-16 | J. M. Huber Corporation | Organic elastomers containing kaolin clay modified with isocyanate coupling agents and mercaptoethanol |
| US4545390A (en) | 1982-09-22 | 1985-10-08 | C. R. Bard, Inc. | Steerable guide wire for balloon dilatation procedure |
| US4643184A (en) | 1982-09-29 | 1987-02-17 | Mobin Uddin Kazi | Embolus trap |
| US4512338A (en) | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
| US4503569A (en) | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
| US4531916A (en) | 1983-07-08 | 1985-07-30 | W. L. Gore & Associates, Inc. | Dental implant with expanded PTFE gingival interface |
| GB8428109D0 (en) | 1984-11-07 | 1984-12-12 | Biocompatibles Ltd | Biocompatible surfaces |
| US5104392A (en) | 1985-03-22 | 1992-04-14 | Massachusetts Institute Of Technology | Laser spectro-optic imaging for diagnosis and treatment of diseased tissue |
| US4619274A (en) | 1985-04-18 | 1986-10-28 | Advanced Cardiovascular Systems, Inc. | Torsional guide wire with attenuated diameter |
| US4923464A (en) | 1985-09-03 | 1990-05-08 | Becton, Dickinson And Company | Percutaneously deliverable intravascular reconstruction prosthesis |
| US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US5133755A (en) | 1986-01-28 | 1992-07-28 | Thm Biomedical, Inc. | Method and apparatus for diodegradable, osteogenic, bone graft substitute device |
| US4739768B2 (en) | 1986-06-02 | 1995-10-24 | Target Therapeutics Inc | Catheter for guide-wire tracking |
| US4737152A (en) | 1986-07-02 | 1988-04-12 | Becton, Dickinson And Company | Catheter assembly |
| FR2606641B1 (fr) | 1986-11-17 | 1991-07-12 | Promed | Dispositif filtrant pour caillots sanguins |
| CA1340581C (fr) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Neomorphogenese chimerique d'organes par implatation cellulaire controlee, utilisant des matrices artificielles |
| AU613886B2 (en) | 1986-11-29 | 1991-08-15 | Terumo Kabushiki Kaisha | Catheter equipped with balloon |
| DE3644588C1 (de) | 1986-12-27 | 1988-03-10 | Ethicon Gmbh | Implantat und Verfahren zu seiner Herstellung |
| US4890612A (en) | 1987-02-17 | 1990-01-02 | Kensey Nash Corporation | Device for sealing percutaneous puncture in a vessel |
| JPS63238872A (ja) | 1987-03-25 | 1988-10-04 | テルモ株式会社 | 管状器官内腔の内径確保用器具 |
| US4871542A (en) | 1987-04-30 | 1989-10-03 | Ferring Service Center, N.V. | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract |
| US5108438A (en) | 1989-03-02 | 1992-04-28 | Regen Corporation | Prosthetic intervertebral disc |
| US4813934A (en) | 1987-08-07 | 1989-03-21 | Target Therapeutics | Valved catheter device and method |
| DK163713C (da) | 1987-09-02 | 1992-09-07 | Ole Gyring Nieben | Anordning til anbringelse af et partielt kateter i et legemshulrum |
| US5035891A (en) | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
| AU2800489A (en) | 1987-12-02 | 1989-07-05 | Tyndale Plains-Hunter Ltd. | Hydrophilic polyurethanes of improved strength |
| US4832047A (en) | 1987-12-15 | 1989-05-23 | Target Therapeutics | Guide wire device |
| FR2632864B2 (fr) | 1987-12-31 | 1990-10-19 | Biomat Sarl | Systeme filtrant elastique anti-embolique pour veine cave et ensemble de moyens pour sa mise en place |
| US4884579A (en) | 1988-04-18 | 1989-12-05 | Target Therapeutics | Catheter guide wire |
| US4832055A (en) | 1988-07-08 | 1989-05-23 | Palestrant Aubrey M | Mechanically locking blood clot filter |
| US5374261A (en) | 1990-07-24 | 1994-12-20 | Yoon; Inbae | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor |
| US5019090A (en) | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
| US5092877A (en) | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
| US4913141A (en) | 1988-10-25 | 1990-04-03 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
| US4994069A (en) | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
| GB2226245A (en) | 1988-11-18 | 1990-06-27 | Alan Crockard | Endoscope, remote actuator and aneurysm clip applicator. |
| NZ228382A (en) | 1989-03-17 | 1992-08-26 | Carter Holt Harvey Plastic Pro | Drug administering coil-like device for insertion in body cavity of animal |
| US4985467A (en) | 1989-04-12 | 1991-01-15 | Scotfoam Corporation | Highly absorbent polyurethane foam |
| US5312356A (en) | 1989-05-22 | 1994-05-17 | Target Therapeutics | Catheter with low-friction distal segment |
| US4955862A (en) | 1989-05-22 | 1990-09-11 | Target Therapeutics, Inc. | Catheter and catheter/guide wire device |
| US5061914A (en) | 1989-06-27 | 1991-10-29 | Tini Alloy Company | Shape-memory alloy micro-actuator |
| US5622188A (en) | 1989-08-18 | 1997-04-22 | Endovascular Instruments, Inc. | Method of restoring reduced or absent blood flow capacity in an artery |
| EP0415332B1 (fr) | 1989-08-25 | 1995-01-11 | SciMed Life Systems, Inc. | Dispositif d'échange de cathéter par maintient du fil de guidage |
| DE3929883A1 (de) | 1989-09-08 | 1991-03-14 | Akzo Gmbh | Verfahren zur herstellung von desoxycellulosevervindungen |
| US5525348A (en) | 1989-11-02 | 1996-06-11 | Sts Biopolymers, Inc. | Coating compositions comprising pharmaceutical agents |
| US5061274A (en) | 1989-12-04 | 1991-10-29 | Kensey Nash Corporation | Plug device for sealing openings and method of use |
| US5851206A (en) | 1990-03-13 | 1998-12-22 | The Regents Of The University Of California | Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment |
| US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US5354295A (en) | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US6425893B1 (en) | 1990-03-13 | 2002-07-30 | The Regents Of The University Of California | Method and apparatus for fast electrolytic detachment of an implant |
| US6083220A (en) | 1990-03-13 | 2000-07-04 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US5013316A (en) | 1990-03-26 | 1991-05-07 | Marlowe Goble E | Soft tissue anchor system |
| US5064434A (en) | 1990-04-04 | 1991-11-12 | Haber Terry M | Genitourinary implant |
| US5108407A (en) | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
| CA2038605C (fr) | 1990-06-15 | 2000-06-27 | Leonard Pinchuk | Protheses et autres de polymere polycarbonate urethane resistant aux fissures |
| US5229431A (en) | 1990-06-15 | 1993-07-20 | Corvita Corporation | Crack-resistant polycarbonate urethane polymer prostheses and the like |
| US5098440A (en) | 1990-08-14 | 1992-03-24 | Cordis Corporation | Object retrieval method and apparatus |
| US5133731A (en) | 1990-11-09 | 1992-07-28 | Catheter Research, Inc. | Embolus supply system and method |
| US5167624A (en) | 1990-11-09 | 1992-12-01 | Catheter Research, Inc. | Embolus delivery system and method |
| US5109867A (en) | 1991-04-19 | 1992-05-05 | Target Therapeutics | Extendable guidewire assembly |
| US5228453A (en) | 1991-05-07 | 1993-07-20 | Target Therapeutics, Inc. | Catheter guide wire |
| US5296518A (en) | 1991-05-24 | 1994-03-22 | Hampshire Chemical Corp. | Hydrophilic polyurethaneurea foams containing no toxic leachable additives and method to produce such foams |
| US5217484A (en) | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
| US5308342A (en) | 1991-08-07 | 1994-05-03 | Target Therapeutics, Inc. | Variable stiffness catheter |
| US5188621A (en) | 1991-08-26 | 1993-02-23 | Target Therapeutics Inc. | Extendable guidewire assembly |
| US5304194A (en) | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
| US5226911A (en) | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
| US5256146A (en) | 1991-10-11 | 1993-10-26 | W. D. Ensminger | Vascular catheterization system with catheter anchoring feature |
| CA2081424C (fr) | 1991-10-25 | 2008-12-30 | Timothy A. Chuter | Prothese transluminale dilatable pour la reparation des anevrismes |
| US5258000A (en) | 1991-11-25 | 1993-11-02 | Cook Incorporated | Tissue aperture repair device |
| US5261916A (en) | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
| US5234437A (en) | 1991-12-12 | 1993-08-10 | Target Therapeutics, Inc. | Detachable pusher-vasoocclusion coil assembly with threaded coupling |
| ATE187053T1 (de) | 1991-12-12 | 1999-12-15 | Target Therapeutics Inc | Entkuppelbare, verschiebbare, gefässverschliessende spirale mit ineinandergreifenden kupplungselementen |
| DE69307299T2 (de) | 1992-02-14 | 1997-04-30 | Board of Regents, the University of Texas System, Austin, Tex. | Mehrphasiges, biologisch abbaubares implantat/träger und verfahren zu seiner herstellung |
| US5263964A (en) | 1992-05-06 | 1993-11-23 | Coil Partners Ltd. | Coaxial traction detachment apparatus and method |
| ES2150427T3 (es) | 1992-06-02 | 2000-12-01 | Bard Inc C R | Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo. |
| US5629008A (en) | 1992-06-02 | 1997-05-13 | C.R. Bard, Inc. | Method and device for long-term delivery of drugs |
| US5290295A (en) | 1992-07-15 | 1994-03-01 | Querals & Fine, Inc. | Insertion tool for an intraluminal graft procedure |
| US5350397A (en) | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
| US5356388A (en) | 1992-09-22 | 1994-10-18 | Target Therapeutics, Inc. | Perfusion catheter system |
| USRE37117E1 (en) | 1992-09-22 | 2001-03-27 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
| US5250071A (en) | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
| US5312415A (en) | 1992-09-22 | 1994-05-17 | Target Therapeutics, Inc. | Assembly for placement of embolic coils using frictional placement |
| IL106946A0 (en) | 1992-09-22 | 1993-12-28 | Target Therapeutics Inc | Detachable embolic coil assembly |
| US5382259A (en) | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
| IL103737A (en) | 1992-11-13 | 1997-02-18 | Technion Res & Dev Foundation | Stapler device particularly useful in medical suturing |
| US5690666A (en) | 1992-11-18 | 1997-11-25 | Target Therapeutics, Inc. | Ultrasoft embolism coils and process for using them |
| US5318527A (en) | 1992-12-22 | 1994-06-07 | Advanced Cardiovascular Systems, Inc. | Fixed wire catheter exchange device |
| US5423849A (en) | 1993-01-15 | 1995-06-13 | Target Therapeutics, Inc. | Vasoocclusion device containing radiopaque fibers |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5380334A (en) | 1993-02-17 | 1995-01-10 | Smith & Nephew Dyonics, Inc. | Soft tissue anchors and systems for implantation |
| US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
| US5800453A (en) | 1993-04-19 | 1998-09-01 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking hooks and slots |
| US5925059A (en) | 1993-04-19 | 1999-07-20 | Target Therapeutics, Inc. | Detachable embolic coil assembly |
| US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
| US5409015A (en) | 1993-05-11 | 1995-04-25 | Target Therapeutics, Inc. | Deformable tip super elastic guidewire |
| US5531715A (en) | 1993-05-12 | 1996-07-02 | Target Therapeutics, Inc. | Lubricious catheters |
| WO1995001123A2 (fr) | 1993-06-24 | 1995-01-12 | Conceptus, Inc. | Dispositif de type fil de guidage et d'utilisation dudit dispositif |
| US5522895A (en) | 1993-07-23 | 1996-06-04 | Rice University | Biodegradable bone templates |
| US5405322A (en) | 1993-08-12 | 1995-04-11 | Boston Scientific Corporation | Method for treating aneurysms with a thermal source |
| AU7564494A (en) | 1993-08-13 | 1995-03-14 | Smith & Nephew Richards Inc. | Microporous polymeric foams and microtextured surfaces |
| DE69426414T2 (de) | 1993-09-24 | 2001-05-03 | Takiron Co. Ltd., Osaka | Implantatmaterial |
| US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
| US5423829A (en) | 1993-11-03 | 1995-06-13 | Target Therapeutics, Inc. | Electrolytically severable joint for endovascular embolic devices |
| US5624449A (en) | 1993-11-03 | 1997-04-29 | Target Therapeutics | Electrolytically severable joint for endovascular embolic devices |
| US5615232A (en) | 1993-11-24 | 1997-03-25 | Novatel Communications Ltd. | Method of estimating a line of sight signal propagation time using a reduced-multipath correlation function |
| US5730127A (en) | 1993-12-03 | 1998-03-24 | Avitall; Boaz | Mapping and ablation catheter system |
| US5487385A (en) | 1993-12-03 | 1996-01-30 | Avitall; Boaz | Atrial mapping and ablation catheter system |
| US5618314A (en) | 1993-12-13 | 1997-04-08 | Harwin; Steven F. | Suture anchor device |
| US5935060A (en) | 1996-07-12 | 1999-08-10 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including list based processing |
| US5486507A (en) | 1994-01-14 | 1996-01-23 | Fuisz Technologies Ltd. | Porous particle aggregate and method therefor |
| US5429605A (en) | 1994-01-26 | 1995-07-04 | Target Therapeutics, Inc. | Microballoon catheter |
| US5417708A (en) | 1994-03-09 | 1995-05-23 | Cook Incorporated | Intravascular treatment system and percutaneous release mechanism therefor |
| US5686091A (en) | 1994-03-28 | 1997-11-11 | The Johns Hopkins University School Of Medicine | Biodegradable foams for cell transplantation |
| JP2880070B2 (ja) | 1994-03-31 | 1999-04-05 | 株式会社カネカメディックス | 生体内留置部材を有する医療用ワイヤー |
| US6475232B1 (en) | 1996-12-10 | 2002-11-05 | Purdue Research Foundation | Stent with reduced thrombogenicity |
| AU2372295A (en) | 1994-04-29 | 1995-11-29 | Target Therapeutics, Inc. | Method for producing lubricious catheters |
| US5556429A (en) | 1994-05-06 | 1996-09-17 | Advanced Bio Surfaces, Inc. | Joint resurfacing system |
| US6139510A (en) | 1994-05-11 | 2000-10-31 | Target Therapeutics Inc. | Super elastic alloy guidewire |
| US5522819A (en) | 1994-05-12 | 1996-06-04 | Target Therapeutics, Inc. | Dual coil medical retrieval device |
| US5725546A (en) | 1994-06-24 | 1998-03-10 | Target Therapeutics, Inc. | Detachable microcoil delivery catheter |
| US5454795A (en) | 1994-06-27 | 1995-10-03 | Target Therapeutics, Inc. | Kink-free spiral-wound catheter |
| US5522836A (en) | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
| EP0689805B1 (fr) | 1994-06-27 | 2003-05-28 | Corvita Corporation | Endoprothèses de greffes luminales bistables |
| US5769899A (en) | 1994-08-12 | 1998-06-23 | Matrix Biotechnologies, Inc. | Cartilage repair unit |
| US20020055786A1 (en) | 1994-08-16 | 2002-05-09 | Anthony Atala | Reconstruction of urological structures with polymeric matrices |
| KR100341192B1 (ko) | 1994-08-17 | 2002-08-22 | 보스톤 사이언티픽 코포레이션 | 이식편,및이식편을삽입하기위한방법및장치 |
| US5885278A (en) | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
| IL115956A0 (en) | 1994-11-11 | 1996-01-31 | Target Therapeutics Inc | Vasoocclusive device |
| US6372228B1 (en) | 1994-11-15 | 2002-04-16 | Kenton W. Gregory | Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| US5709934A (en) | 1994-11-22 | 1998-01-20 | Tissue Engineering, Inc. | Bipolymer foams having extracellular matrix particulates |
| US5891558A (en) | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
| US5690671A (en) | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
| US5578074A (en) | 1994-12-22 | 1996-11-26 | Target Therapeutics, Inc. | Implant delivery method and assembly |
| US5814062A (en) | 1994-12-22 | 1998-09-29 | Target Therapeutics, Inc. | Implant delivery assembly with expandable coupling/decoupling mechanism |
| IL116561A0 (en) | 1994-12-30 | 1996-03-31 | Target Therapeutics Inc | Severable joint for detachable devices placed within the body |
| DK175166B1 (da) | 1995-01-03 | 2004-06-21 | Cook William Europ | Fremgangsmåde til fremstilling af et aggregat til placering af en embolisationscoil i det vaskulære system og et sådant aggregat samt et apparat til fremføring af aggregatet |
| US5750585A (en) | 1995-04-04 | 1998-05-12 | Purdue Research Foundation | Super absorbent hydrogel foams |
| US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| US5911731A (en) | 1995-04-20 | 1999-06-15 | Target Therapeutics, Inc. | Anatomically shaped vasoocclusive devices |
| US5634926A (en) | 1995-04-25 | 1997-06-03 | Jobe; Richard P. | Surgical bone fixation apparatus |
| US6143007A (en) | 1995-04-28 | 2000-11-07 | Target Therapeutics, Inc. | Method for making an occlusive device |
| US5722989A (en) | 1995-05-22 | 1998-03-03 | The Regents Of The University Of California | Microminiaturized minimally invasive intravascular micro-mechanical systems powered and controlled via fiber-optic cable |
| US5766160A (en) | 1995-06-06 | 1998-06-16 | Target Therapeutics, Inc. | Variable stiffness coils |
| US5624461A (en) | 1995-06-06 | 1997-04-29 | Target Therapeutics, Inc. | Three dimensional in-filling vaso-occlusive coils |
| NO962336L (no) | 1995-06-06 | 1996-12-09 | Target Therapeutics Inc | Vaso-okklusiv spiral |
| US5820917A (en) | 1995-06-07 | 1998-10-13 | Medtronic, Inc. | Blood-contacting medical device and method |
| US5667513A (en) | 1995-06-07 | 1997-09-16 | Smith & Nephew Dyonics Inc. | Soft tissue anchor delivery apparatus |
| US5989242A (en) | 1995-06-26 | 1999-11-23 | Trimedyne, Inc. | Therapeutic appliance releasing device |
| US5725568A (en) | 1995-06-27 | 1998-03-10 | Scimed Life Systems, Inc. | Method and device for recanalizing and grafting arteries |
| US5582619A (en) | 1995-06-30 | 1996-12-10 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils |
| US5853418A (en) | 1995-06-30 | 1998-12-29 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
| EP0913124B1 (fr) | 1995-06-30 | 2003-11-26 | Boston Scientific Limited | Spirale occlusive résistante à l'allongement |
| US6019757A (en) | 1995-07-07 | 2000-02-01 | Target Therapeutics, Inc. | Endoluminal electro-occlusion detection apparatus and method |
| US5782865A (en) | 1995-08-25 | 1998-07-21 | Grotz; Robert Thomas | Stabilizer for human joints |
| US5601600A (en) | 1995-09-08 | 1997-02-11 | Conceptus, Inc. | Endoluminal coil delivery system having a mechanical release mechanism |
| CA2186768C (fr) | 1995-09-29 | 2000-12-12 | Pete Phong Pham | Dispositifs pour occlusion vasculaire, de forme anatomique |
| US6440097B1 (en) | 1995-10-06 | 2002-08-27 | Target Therapeutics, Inc. | Balloon catheter with delivery side holes |
| US5716413A (en) | 1995-10-11 | 1998-02-10 | Osteobiologics, Inc. | Moldable, hand-shapable biodegradable implant material |
| US5658308A (en) | 1995-12-04 | 1997-08-19 | Target Therapeutics, Inc. | Bioactive occlusion coil |
| AU690862B2 (en) | 1995-12-04 | 1998-04-30 | Target Therapeutics, Inc. | Fibered micro vaso-occlusive devices |
| US5882334A (en) | 1995-12-04 | 1999-03-16 | Target Therapeutics, Inc. | Balloon/delivery catheter assembly with adjustable balloon positioning |
| US6017388A (en) | 1996-01-16 | 2000-01-25 | Opta Food Ingredients, Inc. | Starch-emulsifier composition and methods of making |
| US5749894A (en) | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
| US6168622B1 (en) | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
| US5702361A (en) | 1996-01-31 | 1997-12-30 | Micro Therapeutics, Inc. | Method for embolizing blood vessels |
| US6638293B1 (en) | 1996-02-02 | 2003-10-28 | Transvascular, Inc. | Methods and apparatus for blocking flow through blood vessels |
| US5776154A (en) | 1996-02-20 | 1998-07-07 | Cardiothoracic Systems, Inc. | Surgical instruments for making precise incisions in a cardiac vessel |
| US5769870A (en) | 1996-02-20 | 1998-06-23 | Cardiothoracic Systems, Inc. | Perfusion device for maintaining blood flow in a vessel while isolating an anastomosis |
| US5894843A (en) | 1996-02-20 | 1999-04-20 | Cardiothoracic Systems, Inc. | Surgical method for stabilizing the beating heart during coronary artery bypass graft surgery |
| US5976171A (en) | 1996-02-20 | 1999-11-02 | Cardiothoracic Systems, Inc. | Access platform for internal mammary dissection |
| CA2198036C (fr) | 1996-02-20 | 2000-12-05 | Charles S. Taylor | Plate-forme d'acces pour la dissection de l'artere thoracique interne |
| US5925054A (en) | 1996-02-20 | 1999-07-20 | Cardiothoracic Systems, Inc. | Perfusion device for maintaining blood flow in a vessel while isolating an anastomosis |
| US5730757A (en) | 1996-02-20 | 1998-03-24 | Cardiothoracic Systems, Inc. | Access platform for internal mammary dissection |
| CA2197614C (fr) | 1996-02-20 | 2002-07-02 | Charles S. Taylor | Instruments chirurgicaux et procedes de stabilisation du coeur palpitant en cours de pontage aortocoronarien |
| US5871496A (en) | 1996-03-20 | 1999-02-16 | Cardiothoracic Systems, Inc. | Surgical instrument for facilitating the detachment of an artery and the like |
| US5713949A (en) | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
| US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| AU3186897A (en) | 1996-05-08 | 1997-11-26 | Salviac Limited | An occluder device |
| US6190402B1 (en) | 1996-06-21 | 2001-02-20 | Musc Foundation For Research Development | Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same |
| US5980514A (en) | 1996-07-26 | 1999-11-09 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
| US5741331A (en) | 1996-07-29 | 1998-04-21 | Corvita Corporation | Biostable elastomeric polymers having quaternary carbons |
| US5823198A (en) | 1996-07-31 | 1998-10-20 | Micro Therapeutics, Inc. | Method and apparatus for intravasculer embolization |
| US6054142A (en) | 1996-08-01 | 2000-04-25 | Cyto Therapeutics, Inc. | Biocompatible devices with foam scaffolds |
| EP0920467A4 (fr) | 1996-08-26 | 1999-10-13 | Tyndale Plains Hunter Ltd | Polyether-polyurethannes hydrophiles et hydrophobes et utilisations correspondantes |
| US5824081A (en) | 1996-09-13 | 1998-10-20 | Lipomatrix Incorporated | Hydraulic foam tissue implant |
| JP3754145B2 (ja) | 1996-09-20 | 2006-03-08 | 株式会社カネカメディックス | 生体内留置部材を有する医療用ワイヤー |
| AUPO251096A0 (en) | 1996-09-23 | 1996-10-17 | Cardiac Crc Nominees Pty Limited | Polysiloxane-containing polyurethane elastomeric compositions |
| US5895391A (en) | 1996-09-27 | 1999-04-20 | Target Therapeutics, Inc. | Ball lock joint and introducer for vaso-occlusive member |
| US6984240B1 (en) | 1996-10-25 | 2006-01-10 | Target Therapeutics, Inc. | Detachable multidiameter vasoocclusive coil |
| US6019771A (en) | 1996-12-02 | 2000-02-01 | Cardiothoracic Systems, Inc. | Devices and methods for minimally invasive harvesting of a vessel especially the saphenous vein for coronary bypass grafting |
| AU6876498A (en) | 1997-04-03 | 1998-10-22 | Point Biomedical Corporation | Intravesical drug delivery system |
| US6111052A (en) | 1997-04-30 | 2000-08-29 | Medtronic, Inc. | Polyurethane and polyurea biomaterials for use in medical devices |
| US6190311B1 (en) | 1997-05-02 | 2001-02-20 | Cardiothoracic Systems, Inc. | Retractor and instrument platform for a less invasive cardiovascular surgical procedure |
| US5891159A (en) | 1997-05-02 | 1999-04-06 | Cardiothoratic Systems, Inc. | Automatic purse string suture device |
| US5891192A (en) | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
| US5951539A (en) | 1997-06-10 | 1999-09-14 | Target Therpeutics, Inc. | Optimized high performance multiple coil spiral-wound vascular catheter |
| US6531154B1 (en) | 1997-06-10 | 2003-03-11 | Brown University Research Foundation | Modulated release from biocompatible polymers |
| US5830183A (en) | 1997-06-30 | 1998-11-03 | Schneider (Usa) Inc | Clip device for vascular catheter |
| AU8102698A (en) | 1997-07-02 | 1999-01-25 | Novo Nordisk A/S | Starch conversion process using thermostable isoamylases from (sulfolobus) |
| US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
| US5944733A (en) | 1997-07-14 | 1999-08-31 | Target Therapeutics, Inc. | Controlled detachable vasoocclusive member using mechanical junction and friction-enhancing member |
| AUPO787897A0 (en) | 1997-07-14 | 1997-08-07 | Cardiac Crc Nominees Pty Limited | Silicon-containing chain extenders |
| US6042592A (en) | 1997-08-04 | 2000-03-28 | Meadox Medicals, Inc. | Thin soft tissue support mesh |
| US6063070A (en) | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
| EP1003422B1 (fr) | 1997-08-05 | 2006-06-14 | Boston Scientific Limited | Pont detachable de collet d'anevrisme |
| US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
| US5863627A (en) | 1997-08-26 | 1999-01-26 | Cardiotech International, Inc. | Hydrolytically-and proteolytically-stable polycarbonate polyurethane silicone copolymers |
| US6589199B1 (en) | 1997-08-28 | 2003-07-08 | Boston Scientific Corporation | System for implanting a cross-linked polysaccharide fiber and methods of forming and inserting the fiber |
| US5984929A (en) | 1997-08-29 | 1999-11-16 | Target Therapeutics, Inc. | Fast detaching electronically isolated implant |
| US6322576B1 (en) | 1997-08-29 | 2001-11-27 | Target Therapeutics, Inc. | Stable coil designs |
| US6177522B1 (en) | 1997-11-07 | 2001-01-23 | Salviac Limited | Biostable polycarbonate urethane products |
| IE980920A1 (en) | 1997-11-07 | 1999-05-19 | Salviac Ltd | An embolic protection device |
| AU739610B2 (en) | 1997-11-07 | 2001-10-18 | Salviac Limited | Implantable occluder devices for medical use |
| US6135193A (en) | 1997-11-17 | 2000-10-24 | Lloyd; Virginia R. | Auto shade with decorative reflective surface |
| US5911728A (en) | 1997-11-18 | 1999-06-15 | Cardiothoracic Systems, Inc. | Cannula purse string suture clamping device |
| US6159165A (en) | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
| US6136015A (en) | 1998-08-25 | 2000-10-24 | Micrus Corporation | Vasoocclusive coil |
| US6036720A (en) | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
| US6203547B1 (en) | 1997-12-19 | 2001-03-20 | Target Therapeutics, Inc. | Vaso-occlusion apparatus having a manipulable mechanical detachment joint and a method for using the apparatus |
| SE511312C2 (sv) | 1997-12-22 | 1999-09-06 | Sandvik Ab | Sätt att tillverka whiskerförstärkt keramik s |
| US6011995A (en) | 1997-12-29 | 2000-01-04 | The Regents Of The University Of California | Endovascular device for hyperthermia and angioplasty and method for using the same |
| US6001111A (en) | 1998-01-16 | 1999-12-14 | Cardiothoracic Systems, Inc. | Low profile vessel occluder with and without detachable applicator |
| WO1999039649A1 (fr) | 1998-02-10 | 1999-08-12 | Dubrul William R | Appareil d'occlusion, d'ancrage et de mise en tension flottant et procedes d'utilisation |
| US5941888A (en) | 1998-02-18 | 1999-08-24 | Target Therapeutics, Inc. | Vaso-occlusive member assembly with multiple detaching points |
| US6015422A (en) | 1998-02-18 | 2000-01-18 | Montefiore Hospital And Medical Center | Collapsible low-profile vascular graft implantation instrument and method for use thereof |
| US6077260A (en) | 1998-02-19 | 2000-06-20 | Target Therapeutics, Inc. | Assembly containing an electrolytically severable joint for endovascular embolic devices |
| US6824550B1 (en) | 2000-04-06 | 2004-11-30 | Norbon Medical, Inc. | Guidewire for crossing occlusions or stenosis |
| US6379374B1 (en) | 1998-10-22 | 2002-04-30 | Cordis Neurovascular, Inc. | Small diameter embolic coil hydraulic deployment system |
| US6068644A (en) | 1998-03-10 | 2000-05-30 | Cordis Corporation | Embolic coil hydraulic deployment system having improved catheter |
| US6183491B1 (en) | 1998-03-10 | 2001-02-06 | Cordis Corporation | Embolic coil deployment system with improved embolic coil |
| US6063100A (en) | 1998-03-10 | 2000-05-16 | Cordis Corporation | Embolic coil deployment system with improved embolic coil |
| US6113622A (en) | 1998-03-10 | 2000-09-05 | Cordis Corporation | Embolic coil hydraulic deployment system |
| US6117142A (en) | 1998-03-10 | 2000-09-12 | Cordis Corporation | Embolic coil hydraulic deployment system with improved syringe injector |
| US6183461B1 (en) | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
| US5925060A (en) | 1998-03-13 | 1999-07-20 | B. Braun Celsa | Covered self-expanding vascular occlusion device |
| US6036706A (en) | 1998-03-13 | 2000-03-14 | Cardiothoracic Systems, Inc. | Vascular clamp and method for using the same |
| US6042563A (en) | 1998-03-27 | 2000-03-28 | Cardiothoracic Systems, Inc. | Methods and apparatus for occluding a blood vessel |
| AUPP268898A0 (en) | 1998-03-31 | 1998-04-23 | Cardiac Crc Nominees Pty Limited | High modulus polyurethane compositions |
| IE980241A1 (en) | 1998-04-02 | 1999-10-20 | Salviac Ltd | Delivery catheter with split sheath |
| US6190357B1 (en) | 1998-04-21 | 2001-02-20 | Cardiothoracic Systems, Inc. | Expandable cannula for performing cardiopulmonary bypass and method for using same |
| US6679915B1 (en) | 1998-04-23 | 2004-01-20 | Sdgi Holdings, Inc. | Articulating spinal implant |
| AU760408B2 (en) | 1998-04-27 | 2003-05-15 | Surmodics, Inc. | Bioactive agent release coating |
| US6015424A (en) | 1998-04-28 | 2000-01-18 | Microvention, Inc. | Apparatus and method for vascular embolization |
| US6113629A (en) | 1998-05-01 | 2000-09-05 | Micrus Corporation | Hydrogel for the therapeutic treatment of aneurysms |
| US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
| US6224630B1 (en) | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
| WO1999064491A1 (fr) | 1998-06-05 | 1999-12-16 | Polyganics B.V. | Polyurethanne biomedical; obtention et utilisation |
| US6368316B1 (en) | 1998-06-11 | 2002-04-09 | Target Therapeutics, Inc. | Catheter with composite stiffener |
| US6139564A (en) | 1998-06-16 | 2000-10-31 | Target Therapeutics Inc. | Minimally occlusive flow disruptor stent for bridging aneurysm necks |
| US5935148A (en) | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
| US6117441A (en) | 1998-07-02 | 2000-09-12 | The Population Council, Inc. | Silicone core long term androgen delivery implant |
| US6165193A (en) | 1998-07-06 | 2000-12-26 | Microvention, Inc. | Vascular embolization with an expansible implant |
| US6102917A (en) | 1998-07-15 | 2000-08-15 | The Regents Of The University Of California | Shape memory polymer (SMP) gripper with a release sensing system |
| US6093199A (en) | 1998-08-05 | 2000-07-25 | Endovascular Technologies, Inc. | Intra-luminal device for treatment of body cavities and lumens and method of use |
| US6152943A (en) | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
| US6149664A (en) | 1998-08-27 | 2000-11-21 | Micrus Corporation | Shape memory pusher introducer for vasoocclusive devices |
| US6478773B1 (en) | 1998-12-21 | 2002-11-12 | Micrus Corporation | Apparatus for deployment of micro-coil using a catheter |
| US6500149B2 (en) | 1998-08-31 | 2002-12-31 | Deepak Gandhi | Apparatus for deployment of micro-coil using a catheter |
| US6224610B1 (en) | 1998-08-31 | 2001-05-01 | Micrus Corporation | Shape memory polymer intravascular delivery system with heat transfer medium |
| US6296622B1 (en) | 1998-12-21 | 2001-10-02 | Micrus Corporation | Endoluminal device delivery system using axially recovering shape memory material |
| US7410482B2 (en) | 1998-09-04 | 2008-08-12 | Boston Scientific-Scimed, Inc. | Detachable aneurysm neck bridge |
| EP1109499B1 (fr) | 1998-09-04 | 2007-08-15 | Boston Scientific Limited | Piece de fermeture detachable pour collet anevrysmal |
| US6342062B1 (en) | 1998-09-24 | 2002-01-29 | Scimed Life Systems, Inc. | Retrieval devices for vena cava filter |
| US6355030B1 (en) | 1998-09-25 | 2002-03-12 | Cardiothoracic Systems, Inc. | Instruments and methods employing thermal energy for the repair and replacement of cardiac valves |
| US6277126B1 (en) | 1998-10-05 | 2001-08-21 | Cordis Neurovascular Inc. | Heated vascular occlusion coil development system |
| US6277125B1 (en) | 1998-10-05 | 2001-08-21 | Cordis Neurovascular, Inc. | Embolic coil deployment system with retaining jaws |
| WO2000021470A1 (fr) | 1998-10-12 | 2000-04-20 | Therics, Inc. | Composites pour regeneration de tissu et leurs procedes de fabrication |
| US6187024B1 (en) | 1998-11-10 | 2001-02-13 | Target Therapeutics, Inc. | Bioactive coating for vaso-occlusive devices |
| US6723112B2 (en) | 1998-11-10 | 2004-04-20 | Scimed Life Systems, Inc. | Bioactive three loop coil |
| US6063395A (en) | 1998-11-12 | 2000-05-16 | Leiras Oy | Drug delivery device especially for the delivery of progestins and estrogens |
| US6540780B1 (en) | 1998-11-23 | 2003-04-01 | Medtronic, Inc. | Porous synthetic vascular grafts with oriented ingrowth channels |
| US6102932A (en) | 1998-12-15 | 2000-08-15 | Micrus Corporation | Intravascular device push wire delivery system |
| US6383204B1 (en) | 1998-12-15 | 2002-05-07 | Micrus Corporation | Variable stiffness coil for vasoocclusive devices |
| EP1010396B1 (fr) | 1998-12-16 | 2003-05-07 | Arthesys | Système à cathéter destiné à la libération hydraulique d'une spirale d'embolisation |
| US6835185B2 (en) | 1998-12-21 | 2004-12-28 | Micrus Corporation | Intravascular device deployment mechanism incorporating mechanical detachment |
| US6306159B1 (en) | 1998-12-23 | 2001-10-23 | Depuy Orthopaedics, Inc. | Meniscal repair device |
| US6086591A (en) | 1999-01-29 | 2000-07-11 | Smith & Nephew, Inc. | Soft tissue anchor |
| US6309384B1 (en) | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
| FR2789400B1 (fr) | 1999-02-04 | 2002-12-20 | Bio Ethanol Nord Picardie | Procede de production d'ethanol avec apport frequent de levure |
| US6183518B1 (en) | 1999-02-22 | 2001-02-06 | Anthony C. Ross | Method of replacing nucleus pulposus and repairing the intervertebral disk |
| US6368338B1 (en) | 1999-03-05 | 2002-04-09 | Board Of Regents, The University Of Texas | Occlusion method and apparatus |
| US6221066B1 (en) | 1999-03-09 | 2001-04-24 | Micrus Corporation | Shape memory segmented detachable coil |
| US6428558B1 (en) | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
| US6293923B1 (en) | 1999-03-15 | 2001-09-25 | Innoventions, Inc. | Intravesicular balloon |
| US6602291B1 (en) | 1999-04-05 | 2003-08-05 | Raymedica, Inc. | Prosthetic spinal disc nucleus having a shape change characteristic |
| US6428576B1 (en) | 1999-04-16 | 2002-08-06 | Endospine, Ltd. | System for repairing inter-vertebral discs |
| US20040162519A1 (en) | 1999-04-27 | 2004-08-19 | Helkowski Richard A. | Aortic occlusion balloon cannula |
| WO2000067815A1 (fr) | 1999-05-07 | 2000-11-16 | Salviac Limited | Charpente pour genie tissulaire |
| WO2000067811A1 (fr) | 1999-05-07 | 2000-11-16 | Salviac Limited | Produit de polyether-polyurethane biostable |
| US6096060A (en) | 1999-05-20 | 2000-08-01 | Linvatec Corporation | Bioabsorbable threaded soft tissue anchor system |
| US6139535A (en) | 1999-05-27 | 2000-10-31 | Situs Corporation | Method and apparatus for placement and activation of a medical device within a body cavity |
| US6610317B2 (en) | 1999-05-27 | 2003-08-26 | Acusphere, Inc. | Porous paclitaxel matrices and methods of manufacture thereof |
| US6245107B1 (en) | 1999-05-28 | 2001-06-12 | Bret A. Ferree | Methods and apparatus for treating disc herniation |
| US20020169473A1 (en) | 1999-06-02 | 2002-11-14 | Concentric Medical, Inc. | Devices and methods for treating vascular malformations |
| ATE377395T1 (de) | 1999-06-02 | 2007-11-15 | Sethel Interventional Inc | Intrakorporale verschlussvorrichtung |
| US6379329B1 (en) | 1999-06-02 | 2002-04-30 | Cordis Neurovascular, Inc. | Detachable balloon embolization device and method |
| US6375668B1 (en) | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
| US6280457B1 (en) | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
| US6333029B1 (en) | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
| US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
| US6355699B1 (en) | 1999-06-30 | 2002-03-12 | Ethicon, Inc. | Process for manufacturing biomedical foams |
| US6702848B1 (en) | 1999-07-20 | 2004-03-09 | Peter Paul Zilla | Foam-type vascular prosthesis with well-defined anclio-permissive open porosity |
| US6312421B1 (en) | 1999-07-23 | 2001-11-06 | Neurovasx, Inc. | Aneurysm embolization material and device |
| US7892246B2 (en) | 1999-07-28 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting conduits and closing openings in tissue |
| US7094258B2 (en) | 1999-08-18 | 2006-08-22 | Intrinsic Therapeutics, Inc. | Methods of reinforcing an annulus fibrosis |
| US6425919B1 (en) | 1999-08-18 | 2002-07-30 | Intrinsic Orthopedics, Inc. | Devices and methods of vertebral disc augmentation |
| US6617014B1 (en) | 1999-09-01 | 2003-09-09 | Hydrophilix, Llc | Foam composite |
| US6390096B1 (en) | 1999-09-17 | 2002-05-21 | Pi Medical, Inc. | Needle with pre-loaded implant for snoring treatment |
| AU7448600A (en) | 1999-09-29 | 2001-04-30 | Japan Science And Technology Corporation | High sensitive immunoassay |
| US6664389B1 (en) | 1999-10-01 | 2003-12-16 | National Starch And Chemical Investment Holding Coporation | Highly resistant granular starch |
| US6602261B2 (en) | 1999-10-04 | 2003-08-05 | Microvention, Inc. | Filamentous embolic device with expansile elements |
| US6238403B1 (en) | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
| AU1083101A (en) | 1999-10-12 | 2001-04-23 | Allan R. Will | Methods and devices for protecting a passageway in a body |
| US6383171B1 (en) | 1999-10-12 | 2002-05-07 | Allan Will | Methods and devices for protecting a passageway in a body when advancing devices through the passageway |
| US6592625B2 (en) | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
| US20030153976A1 (en) | 1999-10-20 | 2003-08-14 | Cauthen Joseph C. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
| DE10010840A1 (de) | 1999-10-30 | 2001-09-20 | Dendron Gmbh | Vorrichtung zur Implantation von Occlusionswendeln |
| US6458127B1 (en) | 1999-11-22 | 2002-10-01 | Csaba Truckai | Polymer embolic elements with metallic coatings for occlusion of vascular malformations |
| JP4672947B2 (ja) | 1999-12-06 | 2011-04-20 | ウォーソー・オーソペディック・インコーポレーテッド | 椎間板の治療装置及び方法 |
| US6355063B1 (en) | 2000-01-20 | 2002-03-12 | Impra, Inc. | Expanded PTFE drug delivery graft |
| US6273897B1 (en) | 2000-02-29 | 2001-08-14 | Ethicon, Inc. | Surgical bettress and surgical stapling apparatus |
| US6544225B1 (en) | 2000-02-29 | 2003-04-08 | Cordis Neurovascular, Inc. | Embolic coil hydraulic deployment system with purge mechanism |
| US6346117B1 (en) | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
| WO2001067967A1 (fr) | 2000-03-10 | 2001-09-20 | Radius Medical Technologies, Inc. | Instrument d'extraction chirurgical |
| US6579291B1 (en) | 2000-10-10 | 2003-06-17 | Spinalabs, Llc | Devices and methods for the treatment of spinal disorders |
| US6402750B1 (en) | 2000-04-04 | 2002-06-11 | Spinlabs, Llc | Devices and methods for the treatment of spinal disorders |
| US6689125B1 (en) | 2000-04-04 | 2004-02-10 | Spinalabs, Llc | Devices and methods for the treatment of spinal disorders |
| US8101200B2 (en) | 2000-04-13 | 2012-01-24 | Angiotech Biocoatings, Inc. | Targeted therapeutic agent release devices and methods of making and using the same |
| AU2001261465A1 (en) | 2000-05-12 | 2001-11-26 | The Regents Of The University Of Michigan | Reverse fabrication of porous materials |
| US6514264B1 (en) | 2000-06-01 | 2003-02-04 | Cordis Neurovascular, Inc. | Embolic coil hydraulic deployment system with purge mechanism |
| US6530934B1 (en) | 2000-06-06 | 2003-03-11 | Sarcos Lc | Embolic device composed of a linear sequence of miniature beads |
| US6398718B1 (en) | 2000-06-15 | 2002-06-04 | Innoventions, Inc. | Intravesicular device |
| US20040073243A1 (en) | 2000-06-29 | 2004-04-15 | Concentric Medical, Inc., A Delaware Corporation | Systems, methods and devices for removing obstructions from a blood vessel |
| US6824545B2 (en) | 2000-06-29 | 2004-11-30 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
| IL137090A (en) | 2000-06-29 | 2010-04-15 | Pentech Medical Devices Ltd | Polymeric stent |
| US7285126B2 (en) | 2000-06-29 | 2007-10-23 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
| US7766921B2 (en) | 2000-06-29 | 2010-08-03 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
| US7727243B2 (en) | 2000-06-29 | 2010-06-01 | Concentric Medical., Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
| US20050288686A1 (en) | 2000-06-29 | 2005-12-29 | Concentric Medical, Inc., A Delaware Corporation | Systems, methods and devices for removing obstructions from a blood vessel |
| US8298257B2 (en) | 2000-06-29 | 2012-10-30 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
| US6663650B2 (en) | 2000-06-29 | 2003-12-16 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
| US6730104B1 (en) | 2000-06-29 | 2004-05-04 | Concentric Medical, Inc. | Methods and devices for removing an obstruction from a blood vessel |
| US7727242B2 (en) | 2000-06-29 | 2010-06-01 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
| US6638312B2 (en) | 2000-08-04 | 2003-10-28 | Depuy Orthopaedics, Inc. | Reinforced small intestinal submucosa (SIS) |
| US20050154463A1 (en) | 2000-08-30 | 2005-07-14 | Trieu Hal H. | Spinal nucleus replacement implants and methods |
| US6723108B1 (en) | 2000-09-18 | 2004-04-20 | Cordis Neurovascular, Inc | Foam matrix embolization device |
| US6605101B1 (en) | 2000-09-26 | 2003-08-12 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
| WO2002028372A2 (fr) | 2000-10-06 | 2002-04-11 | Johns Hopkins University | Delivrance systemique de composes par administration non-invasive par la vessie |
| WO2002030399A2 (fr) | 2000-10-11 | 2002-04-18 | Johns Hopkins University | Liberation d'agent therapeutique controlee par polymere |
| US6607538B1 (en) | 2000-10-18 | 2003-08-19 | Microvention, Inc. | Mechanism for the deployment of endovascular implants |
| US6689141B2 (en) | 2000-10-18 | 2004-02-10 | Microvention, Inc. | Mechanism for the deployment of endovascular implants |
| US20040204701A1 (en) | 2000-10-18 | 2004-10-14 | Brian Cox | Mechanism for the deployment of endovascular implants |
| EP1328222B1 (fr) * | 2000-10-27 | 2005-03-30 | SDGI Holdings, Inc. | Systeme de reparation de l'anneau fibreux du disque intervertebral |
| US6589265B1 (en) | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
| US6743251B1 (en) | 2000-11-15 | 2004-06-01 | Scimed Life Systems, Inc. | Implantable devices with polymeric detachment junction |
| US20020072791A1 (en) | 2000-12-07 | 2002-06-13 | Eder Joseph C. | Light-activated multi-point detachment mechanism |
| US6545097B2 (en) | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
| US6623509B2 (en) | 2000-12-14 | 2003-09-23 | Core Medical, Inc. | Apparatus and methods for sealing vascular punctures |
| CA2365376C (fr) | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Utilisation d'implants en mousse renforces ayant une meilleure integrite pour la reparation et la regeneration de tissus mous |
| US6599323B2 (en) | 2000-12-21 | 2003-07-29 | Ethicon, Inc. | Reinforced tissue implants and methods of manufacture and use |
| US6852330B2 (en) | 2000-12-21 | 2005-02-08 | Depuy Mitek, Inc. | Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US7192604B2 (en) | 2000-12-22 | 2007-03-20 | Ethicon, Inc. | Implantable biodegradable devices for musculoskeletal repair or regeneration |
| US20020169497A1 (en) | 2001-01-02 | 2002-11-14 | Petra Wholey | Endovascular stent system and method of providing aneurysm embolization |
| WO2002054943A2 (fr) | 2001-01-10 | 2002-07-18 | Cordis Neurovascular, Inc. | Systeme d'introduction de spire metallique pour embolisation |
| US20030215564A1 (en) | 2001-01-18 | 2003-11-20 | Heller Phillip F. | Method and apparatus for coating an endoprosthesis |
| US6702976B2 (en) | 2001-01-29 | 2004-03-09 | Witold Sokolowski | Cold hibernated elastic memory self-deployable and rigidizable structure and method therefor |
| US6494884B2 (en) | 2001-02-09 | 2002-12-17 | Concentric Medical, Inc. | Methods and devices for delivering occlusion elements |
| US6537569B2 (en) | 2001-02-14 | 2003-03-25 | Microvention, Inc. | Radiation cross-linked hydrogels |
| US7169182B2 (en) | 2001-07-16 | 2007-01-30 | Spinecore, Inc. | Implanting an artificial intervertebral disc |
| US20020169066A1 (en) | 2001-04-16 | 2002-11-14 | Cerabio, L.L.C. | Dense porous structures for use as bone substitutes |
| US6636758B2 (en) | 2001-05-01 | 2003-10-21 | Concentric Medical, Inc. | Marker wire and process for using it |
| US20020177870A1 (en) | 2001-05-25 | 2002-11-28 | Ivan Sepetka | Single lumen balloon catheter |
| US20020183858A1 (en) | 2001-06-05 | 2002-12-05 | Contiliano Joseph H. | Attachment of absorbable tissue scaffolds to scaffold fixation devices |
| US6692510B2 (en) | 2001-06-14 | 2004-02-17 | Cordis Neurovascular, Inc. | Aneurysm embolization device and deployment system |
| US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
| US6702782B2 (en) | 2001-06-26 | 2004-03-09 | Concentric Medical, Inc. | Large lumen balloon catheter |
| US6638245B2 (en) | 2001-06-26 | 2003-10-28 | Concentric Medical, Inc. | Balloon catheter |
| US20030014075A1 (en) | 2001-07-16 | 2003-01-16 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation |
| DE60204021T2 (de) | 2001-07-26 | 2006-01-12 | Oregon Health Sciences University, Portland | Verschlusseinrichtung für ein gefäss und anbringungsvorrichtung |
| AU2002323457A1 (en) | 2001-08-27 | 2003-05-19 | James C. Thomas Jr. | Implant for partial disc and cancellous bone replacement |
| US6811560B2 (en) | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
| JP3993855B2 (ja) | 2001-11-01 | 2007-10-17 | スパイン・ウェイブ・インコーポレーテッド | 脊椎椎間板の回復のための装置 |
| US6811561B2 (en) | 2001-11-15 | 2004-11-02 | Cordis Neurovascular, Inc. | Small diameter deployment system with improved headpiece |
| US6676624B2 (en) | 2001-12-20 | 2004-01-13 | Scimed Life Systems, Inc. | Drainage devices and methods |
| US6953473B2 (en) | 2001-12-20 | 2005-10-11 | Boston Scientific Scimed, Inc. | Detachable device with electrically responsive element |
| US20040068314A1 (en) | 2002-01-16 | 2004-04-08 | Jones Donald K. | Detachable self -expanding aneurysm cover device |
| US6893464B2 (en) | 2002-03-05 | 2005-05-17 | The Regents Of The University Of California | Method and apparatus for providing an expandable spinal fusion cage |
| US20030171773A1 (en) | 2002-03-06 | 2003-09-11 | Carrison Harold F. | Methods for aneurysm repair |
| US6953465B2 (en) | 2002-03-25 | 2005-10-11 | Concentric Medical, Inc. | Containers and methods for delivering vaso-occluding filaments and particles |
| US20030199887A1 (en) | 2002-04-23 | 2003-10-23 | David Ferrera | Filamentous embolization device and method of use |
| US20030204246A1 (en) | 2002-04-25 | 2003-10-30 | Jack Chu | Aneurysm treatment system and method |
| US7008979B2 (en) | 2002-04-30 | 2006-03-07 | Hydromer, Inc. | Coating composition for multiple hydrophilic applications |
| US7044962B2 (en) * | 2002-06-25 | 2006-05-16 | Scimed Life Systems, Inc. | Implantable prosthesis with displaceable skirt |
| US20050171572A1 (en) | 2002-07-31 | 2005-08-04 | Microvention, Inc. | Multi-layer coaxial vaso-occlusive device |
| US20040044391A1 (en) | 2002-08-29 | 2004-03-04 | Stephen Porter | Device for closure of a vascular defect and method of treating the same |
| US7025982B2 (en) | 2002-09-19 | 2006-04-11 | Medtronic, Inc. | Medical assembly suitable for long-term implantation and method for fabricating the same |
| AU2003294226A1 (en) | 2002-09-20 | 2004-04-23 | Flowmedica, Inc. | Method and apparatus for intra aortic substance delivery to a branch vessel |
| WO2004032791A2 (fr) | 2002-09-20 | 2004-04-22 | Flowmedica, Inc. | Procede et dispositif de perfusion selective par catheter intra-renal |
| AU2003278858A1 (en) | 2002-09-20 | 2004-04-08 | Flowmedica, Inc. | Method and apparatus for selective drug infusion via an intraaortic flow diverter delivery catheter |
| US7824701B2 (en) | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
| US6814746B2 (en) | 2002-11-01 | 2004-11-09 | Ev3 Peripheral, Inc. | Implant delivery system with marker interlock |
| US20040115164A1 (en) | 2002-12-17 | 2004-06-17 | Pierce Ryan K. | Soft filament occlusive device delivery system |
| US20050043585A1 (en) | 2003-01-03 | 2005-02-24 | Arindam Datta | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
| US20060015182A1 (en) * | 2003-02-25 | 2006-01-19 | Tsou Paul M | Patch material for intervertebral disc annulus defect repair |
| US7368124B2 (en) | 2003-03-07 | 2008-05-06 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
| US20040193246A1 (en) | 2003-03-25 | 2004-09-30 | Microvention, Inc. | Methods and apparatus for treating aneurysms and other vascular defects |
| EP1623020A4 (fr) | 2003-05-09 | 2007-05-09 | Sigma Aldrich Co | Approches genomique et proteomique en vue du developpement de milieux de culture de cellules |
| AU2004241111B2 (en) | 2003-05-15 | 2010-05-27 | Dsm Ip Assets B.V | Manufacture and use of implantable reticulated elastomeric matrices |
| US6997929B2 (en) | 2003-05-16 | 2006-02-14 | Spine Wave, Inc. | Tissue distraction device |
| US20050060022A1 (en) | 2003-05-21 | 2005-03-17 | Felt Jeffrey C. | Polymer stent |
| US20050021023A1 (en) | 2003-07-23 | 2005-01-27 | Scimed Life Systems, Inc. | System and method for electrically determining position and detachment of an implantable device |
| WO2005037137A2 (fr) | 2003-10-17 | 2005-04-28 | Therics, Inc. | Garniture pour cage spinale, element de remplissage et procede de fabrication |
| US7723395B2 (en) | 2004-04-29 | 2010-05-25 | Kensey Nash Corporation | Compressed porous materials suitable for implant |
| US20050149108A1 (en) | 2003-12-17 | 2005-07-07 | Microvention, Inc. | Implant delivery and detachment system and method |
| US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
| US8012210B2 (en) | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
| US20050165480A1 (en) | 2004-01-23 | 2005-07-28 | Maybelle Jordan | Endovascular treatment devices and methods |
| US20060025802A1 (en) | 2004-07-30 | 2006-02-02 | Sowers William W | Embolic coil delivery system with U-shaped fiber release mechanism |
| US20060025801A1 (en) | 2004-07-30 | 2006-02-02 | Robert Lulo | Embolic device deployment system with filament release |
| US7918872B2 (en) | 2004-07-30 | 2011-04-05 | Codman & Shurtleff, Inc. | Embolic device delivery system with retractable partially coiled-fiber release |
| US7476249B2 (en) | 2004-08-06 | 2009-01-13 | Frank Robert E | Implantable prosthesis for positioning and supporting a breast implant |
| CN104523313B (zh) | 2004-08-25 | 2018-05-18 | 微仙美国有限公司 | 植入物装置递送系统 |
| US20060052816A1 (en) | 2004-08-31 | 2006-03-09 | Cook Incorporated | Device for treating an aneurysm |
| US7597703B2 (en) | 2004-09-07 | 2009-10-06 | Medtronic Vascular, Inc. | Mechanically expandable occluder |
| US20060069323A1 (en) | 2004-09-24 | 2006-03-30 | Flowmedica, Inc. | Systems and methods for bi-lateral guidewire cannulation of branched body lumens |
| US20060106420A1 (en) | 2004-11-12 | 2006-05-18 | Medtronic Vascular, Inc. | Patch for treating a septal defect |
| US20060116709A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
| US8771294B2 (en) | 2004-11-26 | 2014-07-08 | Biomerix Corporation | Aneurysm treatment devices and methods |
| US20060116713A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
| US20060116714A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Coupling and release devices and methods for their assembly and use |
| US7708754B2 (en) | 2005-06-02 | 2010-05-04 | Codman & Shurtleff, Pc | Stretch resistant embolic coil delivery system with mechanical release mechanism |
| US7819892B2 (en) | 2005-06-02 | 2010-10-26 | Codman & Shurtleff, Inc. | Embolic coil delivery system with spring wire release mechanism |
| US7708755B2 (en) | 2005-06-02 | 2010-05-04 | Codman & Shurtleff Inc. | Stretch resistant embolic coil delivery system with combined mechanical and pressure release mechanism |
| US20060282112A1 (en) | 2005-06-09 | 2006-12-14 | Stephen Griffin | Method and apparatus for enhanced electrolytic detachment |
| WO2007134290A2 (fr) | 2006-05-12 | 2007-11-22 | Ev3, Inc. | Système de mise en place d'implant pourvu de verrouillages à marqueurs multiples |
| JP5179089B2 (ja) | 2006-07-28 | 2013-04-10 | テルモ株式会社 | 医療用長尺体 |
-
2003
- 2003-12-24 US US10/746,563 patent/US7763077B2/en not_active Expired - Fee Related
-
2004
- 2004-12-23 JP JP2006547415A patent/JP2007531557A/ja active Pending
- 2004-12-23 AU AU2004311838A patent/AU2004311838A1/en not_active Abandoned
- 2004-12-23 EP EP04815520A patent/EP1697082A2/fr not_active Withdrawn
- 2004-12-23 CA CA002551133A patent/CA2551133A1/fr not_active Abandoned
- 2004-12-23 WO PCT/US2004/043455 patent/WO2005065280A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004311838A1 (en) | 2005-07-21 |
| JP2007531557A (ja) | 2007-11-08 |
| US7763077B2 (en) | 2010-07-27 |
| EP1697082A2 (fr) | 2006-09-06 |
| US20050149046A1 (en) | 2005-07-07 |
| WO2005065280A2 (fr) | 2005-07-21 |
| WO2005065280A3 (fr) | 2007-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7763077B2 (en) | Repair of spinal annular defects and annulo-nucleoplasty regeneration | |
| US20070162131A1 (en) | Repair of spinal annular defects | |
| AU2004241111B2 (en) | Manufacture and use of implantable reticulated elastomeric matrices | |
| US20070190108A1 (en) | High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair | |
| US9050176B2 (en) | At least partially resorbable reticulated elastomeric matrix elements and methods of making same | |
| US8801801B2 (en) | At least partially resorbable reticulated elastomeric matrix elements and methods of making same | |
| US9308076B2 (en) | Bi-phasic compressed porous reinforcement materials suitable for implant | |
| US20100318108A1 (en) | Composite mesh devices and methods for soft tissue repair | |
| US9808351B2 (en) | In-situ formed intervertebral fusion device and method | |
| WO2004062531A1 (fr) | Matrices elastomeres reticulees, procede de fabrication correspondant et utilisation de ces matrices dans des dispositifs implantables | |
| CN101472564A (zh) | 高性能网状弹性基质 | |
| HK1120419A (en) | Reticulated elastomeric matrices, their manufacture and use in implantable devices | |
| HK1130674A (en) | High performance reticulated elastomeric matrix |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20101223 |